Núbia Muñóz

Active 1968–2022

Also published as
Nubia Muñóz · NUBIA MUÑOZ · Nubia Muñoz
129
Papers
43,056
Citations
102
h-index
129
i10-index

Citations

Citations per year for Núbia Muñóz1971: 3 citations1974: 3 citations1975: 2 citations1976: 2 citations1977: 5 citations1978: 2 citations1979: 2 citations1980: 8 citations1981: 4 citations1982: 8 citations1983: 2 citations1984: 1 citations1985: 6 citations1986: 3 citations1987: 7 citations1988: 4 citations1989: 17 citations1990: 23 citations1991: 28 citations1992: 33 citations1993: 22 citations1994: 52 citations1995: 36 citations1996: 58 citations1997: 47 citations1998: 67 citations1999: 89 citations2000: 102 citations2001: 111 citations2002: 158 citations2003: 291 citations2004: 225 citations2005: 343 citations2006: 388 citations2007: 406 citations2008: 449 citations2009: 392 citations2010: 348 citations2011: 370 citations2012: 324 citations2013: 276 citations2014: 227 citations2015: 262 citations2016: 201 citations2017: 245 citations2018: 188 citations2019: 879 citations2020: 750 citations2021: 716 citations2022: 476 citations2023: 336 citations2024: 522 citations2025: 194 citations2026: 3 citations1972–1973: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,428 citing papers, 22.4% of this breakdownChina: 720 citing papers, 6.7% of this breakdownUnited Kingdom: 662 citing papers, 6.1% of this breakdownFrance: 579 citing papers, 5.3% of this breakdownItaly: 441 citing papers, 4.1% of this breakdownGermany: 415 citing papers, 3.8% of this breakdownNetherlands: 366 citing papers, 3.4% of this breakdownCanada: 355 citing papers, 3.3% of this breakdownSpain: 345 citing papers, 3.2% of this breakdownIndia: 277 citing papers, 2.6% of this breakdownAustralia: 275 citing papers, 2.5% of this breakdownBrazil: 219 citing papers, 2% of this breakdown
0%22.4%Other 34.6%

Fields

  • Medicine82.1%
  • Biochemistry, Genetics and Molecular Biology8.3%
  • Immunology and Microbiology4.2%
  • Dentistry1.7%
  • Social Sciences0.8%
  • Computer Science0.4%
  • Other2.5%

Topics

  • Cervical Cancer and HPV Research20.3%
  • Head and Neck Cancer Studies6.7%
  • Genital Health and Disease5%
  • Reproductive tract infections research4.4%
  • Hepatitis B Virus Studies4%
  • Endometrial and Cervical Cancer Treatments3.6%
  • Other56%

Coauthors

All papers

Open in search
  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clara Menéndez, Efrén Javier Domingo, Julio Velasco, Ashrafun Nessa, Saibua C Bunnag Chichareon, You‐Lin Qiao, Enrique Lerma, Suzanne M. Garland, Toshiyuki Sasagawa, Annabelle Ferrera, Doudja Hammouda, Luciano Mariani, Adela Pelayo, I Steiner, Esther Oliva, Chris J.L.M. Meijer, Waleed Al-Jassar, Eugénia Cruz, Thomas C. Wright, A Puras, Cecilia Llave, Maria Tzardi, Θεόδωρος Αγοραστός, Victoria García-Barriola, Christine Clavel, Jaume Ordï, Miguel Andújar, Xavier Castellsagué, Gloria Inés Sánchez, Andrzej Nowakowski, Jacob Bornstein, Nubia Muñóz, F. Xavier Bosch - The Lancet Oncology 2010 cited by 2,728

  2. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

    Authors: , , , , , , , - New England Journal of Medicine 2003 cited by 6,297

  3. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

    Authors: , , , , , , - The Lancet Infectious Diseases 2007 cited by 1,669

  4. Burden of Human Papillomavirus (HPV)-Related Cancers Attributable to HPVs 6/11/16/18/31/33/45/52 and 58

    Authors: , , , , , , , , , , , , , , , , , , , - JNCI Cancer Spectrum 2018 cited by 225

  5. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oluseyi F. Ajayi, Flora Duarte, Ashrafun Nessa, Leopoldo Tinoco, Marco A. Durán-Padilla, Edyta C. Pirog, Halina Viarheichyk, Hesler Morales, Valérie Costes, Ana Félix, Maria Julieta V. Germar, M. Mena, Arzu Ruacan, Asha Jain, Ravi Mehrotra, Marc T. Goodman, Luis Estuardo Lombardi, Annabelle Ferrera, Sani Malami, Estela I. Albanesi, Pablo Dabed, Carla Molina, Rubén López‐Revilla, Václav Mandys, Manuel González, Julio Velasco, Ignacio G. Bravo, Wim Quint, Michael Pawlita, Núbia Muñóz, Silvia de Sanjosé, F. Xavier Bosch - JNCI Journal of the National Cancer Institute 2016 cited by 752

  6. Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

    Authors: , , , , , , , , , , , , , - Clinical Infectious Diseases 2016 cited by 484

  7. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

    Authors: , , , , - British Journal of Cancer 2003 cited by 1,570

  8. Chapter 1: HPV in the etiology of human cancer

    Authors: , , , - Vaccine 2006 cited by 1,368

  9. Role of Human Papillomavirus in Penile Carcinomas Worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jose D. Mota, Robert Jach, Julio Velasco, Carla Carrilho, Rubén López‐Revilla, Marc T. Goodman, Wim Quint, Xavier Castellsagué, Ignacio G. Bravo, Michael Pawlita, Nubia Muñóz, F. Xavier Bosch, Silvia de Sanjosé - European Urology 2016 cited by 293

  10. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

    Authors: , , , , , , , , , , , , , - British Journal of Cancer 2011 cited by 346

  11. Epidemiology and Natural History of Human Papillomavirus Infections and Type-Specific Implications in Cervical Neoplasia

    Authors: , , , , , , , , - Vaccine 2008 cited by 845

  12. Worldwide distribution of human papillomavirus types in cytologically normal women in the International Agency for Research on Cancer HPV prevalence surveys: a pooled analysis

    Authors: , , , , , , , , , , , , , , , , , , , - The Lancet 2005 cited by 1,102

  13. Human papillomavirus DNA prevalence and type distribution in anal carcinomas worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , William G. Quint, Núbia Muñóz, F. Xavier Bosch, Silvia de Sanjosé, on behalf of the HPV VVAP Study Group - International Journal of Cancer 2014 cited by 379

  14. Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions

    Authors: , , , , , , - European Journal of Cancer 2015 cited by 235

  15. Oral cancer in southern India: The influence of smoking, drinking, paan‐chewing and oral hygiene

    Authors: , , , , , , , , , , , - International Journal of Cancer 2002 cited by 370

  16. Worldwide human papillomavirus genotype attribution in over 2000 cases of intraepithelial and invasive lesions of the vulva

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Isabel Alvarado‐Cabrero, Myriam Perrotta, Neerja Bhatla, Θεόδωρος Αγοραστός, Charles F. Lynch, Marc T. Goodman, Hai-Rim Shin, Halina Viarheichyk, Robert Jach, M.O.L. Eugenia Cruz, Julio Velasco, Carla Molina, Jacob Bornstein, Annabelle Ferrera, Efrén Javier Domingo, Cheng-Yang Chou, A A Banjo, Xavier Castellsagué, Michael Pawlita, Belén Lloveras, Wim Quint, Nubia Muñóz, F. Xavier Bosch - European Journal of Cancer 2013 cited by 384

  17. Safety, immunogenicity, and efficacy of quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine in women aged 24–45 years: a randomised, double-blind trial

    Authors: , , , , , , , , , , , , , , , , , - The Lancet 2009 cited by 480

  18. Intestinal metaplasia types and the risk of gastric cancer: A cohort study in Slovenia

    Authors: , , , , , , , , - International Journal of Cancer 1994 cited by 473

  19. Smoking and cervical cancer: pooled analysis of the IARC multi-centric case–control study

    Authors: , , , , , , , - Cancer Causes & Control 2003 cited by 448

  20. Against which human papillomavirus types shall we vaccinate and screen? the international perspective

    Authors: , , , , , , , - International Journal of Cancer 2004 cited by 1,110

  21. Worldwide Human Papillomavirus Etiology of Cervical Adenocarcinoma and Its Cofactors: Implications for Screening and Prevention

    Authors: , , , , , , , , , , , - JNCI Journal of the National Cancer Institute 2006 cited by 700

  22. The Impact of Quadrivalent Human Papillomavirus (HPV; Types 6, 11, 16, and 18) L1 Virus‐Like Particle Vaccine on Infection and Disease Due to Oncogenic Nonvaccine HPV Types in Generally HPV‐Naive Women Aged 16–26 Years

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Lisa Lupinacci, Katherine Giacoletti, Heather L. Sings, Margaret K. James, Teresa M. Hesley, Eliav Barr - The Journal of Infectious Diseases 2009 cited by 627

  23. Chapter 3: HPV type-distribution in women with and without cervical neoplastic diseases

    Authors: , , , , - Vaccine 2006 cited by 571

  24. Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Human Vaccines 2009 cited by 218